|
2014
|
Invention
|
(2s)-2-[[4-[(1r)-1-[(2,4-diaminopteridin-6-yl)methyl]but-3-ynyl]benzoyl]amin]pentanedioic acid fo... |
|
2013
|
Invention
|
Combination of 10-propargyl-10-deazaaminopterin and erlotinib for the treatment of non-small cell... |
|
|
Invention
|
Optically pure diastereomers of 10-propargyl-10-deazaaminopterin and methods of using same for th... |
|
2011
|
Invention
|
Methods for extending progression-free survival using 10-propargyl-10-deazaaminopterin.
The pres... |
|
|
Invention
|
Methods for extending progression-free survival using 10-propargyl-10-deazaaminopterin. The prese... |
|
|
Invention
|
Methods for treating methotrexate-resistant disorders with 10-propargyl-10-deazaaminopterin.
The... |
|
|
Invention
|
Methods for treating methotrexate-resistant disorders with 10-propargyl-10-deazaaminopterin. The ... |
|
2010
|
Invention
|
Methods for assessing cancer for increased sensitivity to 10-propargyl-10-deazaaminopterin by ass... |
|
|
Invention
|
Optically pure diastereomers of 10-propargyl-10-deazaaminopterin and methods of using same. The p... |
|
|
Invention
|
Optically pure diastereomers of 10-propargyl-10-deazaaminopterin and methods of using same.
The ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer. |
|
2008
|
Invention
|
Dt-diaphorase-active agents for treatment of pediatric tumors. The present invention is directed ... |
|
2007
|
Invention
|
Preparation and use of a stable formulation of allosteric effector compounds.
A pharmaceutical c... |
|
2006
|
G/S
|
Chemicals used in industry, science and photography; unprocessed artificial resins, unprocessed p... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer |
|
2005
|
Invention
|
Methods and compositions to reduce tissue irritation in parenteral formulations.
Compositions co... |
|
|
Invention
|
Methods and compositions to reduce tissue irritation in parenteral formulations. Compositions com... |
|
|
Invention
|
Compositions of allosteric hemoglobin modifiers and methods of making the same.
The present inve... |
|
|
Invention
|
Coadministration of radiation, efaproxiral sodium, and supplemental oxygen for the treatment of c... |
|
|
Invention
|
Compositions of allosteric hemoglobin modifiers and methods of making the same. ABSTRACT The pres... |
|
|
Invention
|
Crystalline and amorphous forms of efaproxiral sodium. There are provided in accordance with the ... |
|
2004
|
Invention
|
Substituted chiral allosteric hemoglobin modifiers.
A family of substituted chiral allosteric ef... |
|
2003
|
Invention
|
Device for using patient blood as diluent in administering pharmaceuticals.
The subject inventio... |
|
|
Invention
|
Device for using patient blood or blood fractions as diluent in administering pharmaceuticals. Th... |
|
2002
|
Invention
|
Substituted chiral allosteric hemoglobin modifiers. A family of substituted chiral allosteric eff... |
|
|
Invention
|
Preparation and use of a stable formulation of allosteric effector compounds. A pharmaceutical co... |
|
|
Invention
|
Methods and reagents to acquire mri signals and images. Method for obtaining BOLD MRI images with... |
|
|
Invention
|
Methods and reagents to acquire mri signals and images. Methods for obtaining BOLD MRI images wit... |
|
2001
|
Invention
|
Allosteric inhibitors of pyruvate kinase. Chemical structures have been identified which alloster... |
|
1999
|
Invention
|
Allosteric inhibitors and activators of pyruvate kinase. Chemical structures have been identified... |
|
|
Invention
|
Neuroprotective composition. Inhibitors of NMDA receptor complex activation and allosteric hemogl... |
